These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33318584)

  • 1. Massively parallel sequencing analysis of 68 gastric-type cervical adenocarcinomas reveals mutations in cell cycle-related genes and potentially targetable mutations.
    Selenica P; Alemar B; Matrai C; Talia KL; Veras E; Hussein Y; Oliva E; Beets-Tan RGH; Mikami Y; McCluggage WG; Kiyokawa T; Weigelt B; Park KJ; Murali R
    Mod Pathol; 2021 Jun; 34(6):1213-1225. PubMed ID: 33318584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic Characterization of HPV-related and Gastric-type Endocervical Adenocarcinoma: Correlation With Subtype and Clinical Behavior.
    Hodgson A; Howitt BE; Park KJ; Lindeman N; Nucci MR; Parra-Herran C
    Int J Gynecol Pathol; 2020 Nov; 39(6):578-586. PubMed ID: 31855952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix.
    Park E; Kim SW; Kim S; Kim HS; Lee JY; Kim YT; Cho NH
    Mod Pathol; 2021 Mar; 34(3):637-646. PubMed ID: 32641744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.
    Wright AA; Howitt BE; Myers AP; Dahlberg SE; Palescandolo E; Van Hummelen P; MacConaill LE; Shoni M; Wagle N; Jones RT; Quick CM; Laury A; Katz IT; Hahn WC; Matulonis UA; Hirsch MS
    Cancer; 2013 Nov; 119(21):3776-83. PubMed ID: 24037752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clinicopathological and Molecular Characteristics of Endocervical Gastric-Type Adenocarcinoma and the Use of Claudin18.2 as a Potential Therapeutic Target.
    Yang J; Peng Y; Ding Y; Liu Y; Wang Y; Liu Y; Liu C
    Mod Pathol; 2024 Oct; 37(10):100569. PubMed ID: 39025403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract.
    Mirkovic J; McFarland M; Garcia E; Sholl LM; Lindeman N; MacConaill L; Dong F; Hirsch M; Nucci MR; Quick CM; Crum CP; McCluggage WG; Howitt BE
    Am J Surg Pathol; 2018 Feb; 42(2):227-233. PubMed ID: 28984674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic alterations caused by HPV integration in a cohort of Chinese endocervical adenocarcinomas.
    Li W; Lei W; Chao X; Song X; Bi Y; Wu H; Wu M; Li L
    Cancer Gene Ther; 2021 Dec; 28(12):1353-1364. PubMed ID: 33398034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and Molecular Differences Between Gastric-type Mucinous Carcinoma and Usual-type Endocervical Adenocarcinoma of the Uterine Cervix.
    Jung H; Bae GE; Kim HM; Kim HS
    Cancer Genomics Proteomics; 2020; 17(5):627-641. PubMed ID: 32859641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and pathological basis of HPV-negative cervical adenocarcinoma seen in a global study.
    Jenkins D; Molijn A; Kazem S; Pirog EC; Alemany L; de Sanjosé S; Dinjens W; Quint W
    Int J Cancer; 2020 Nov; 147(9):2526-2536. PubMed ID: 32474915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive genomic profiling and prognostic analysis of cervical gastric-type mucinous adenocarcinoma.
    Lu S; Shi J; Zhang X; Kong F; Liu L; Dong X; Wang K; Shen D
    Virchows Arch; 2021 Nov; 479(5):893-903. PubMed ID: 33817764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Landscape of genomic alterations in cervical carcinomas.
    Ojesina AI; Lichtenstein L; Freeman SS; Pedamallu CS; Imaz-Rosshandler I; Pugh TJ; Cherniack AD; Ambrogio L; Cibulskis K; Bertelsen B; Romero-Cordoba S; Treviño V; Vazquez-Santillan K; Guadarrama AS; Wright AA; Rosenberg MW; Duke F; Kaplan B; Wang R; Nickerson E; Walline HM; Lawrence MS; Stewart C; Carter SL; McKenna A; Rodriguez-Sanchez IP; Espinosa-Castilla M; Woie K; Bjorge L; Wik E; Halle MK; Hoivik EA; Krakstad C; Gabiño NB; Gómez-Macías GS; Valdez-Chapa LD; Garza-Rodríguez ML; Maytorena G; Vazquez J; Rodea C; Cravioto A; Cortes ML; Greulich H; Crum CP; Neuberg DS; Hidalgo-Miranda A; Escareno CR; Akslen LA; Carey TE; Vintermyr OK; Gabriel SB; Barrera-Saldaña HA; Melendez-Zajgla J; Getz G; Salvesen HB; Meyerson M
    Nature; 2014 Feb; 506(7488):371-5. PubMed ID: 24390348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of gastric-type endocervical adenocarcinoma using next-generation sequencing.
    Garg S; Nagaria TS; Clarke B; Freedman O; Khan Z; Schwock J; Bernardini MQ; Oza AM; Han K; Smith AC; Stockley TL; Rouzbahman M
    Mod Pathol; 2019 Dec; 32(12):1823-1833. PubMed ID: 31308508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of recurrent APOBEC3B alterations with the prognosis of gastric-type cervical adenocarcinoma.
    Liao X; Xia X; Su W; Yan H; Ma Y; Xu L; Luo H; Liu W; Yin D; Zhang WH; Chen HN; Deng Y; Ren Z; Yu Z; Liao F; Chen K; Cao M; Zhang Y; Zhang W; Wang W; Zhao JN; Xu H; Shu Y
    Gynecol Oncol; 2022 Apr; 165(1):105-113. PubMed ID: 35151492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.
    Mackenzie R; Kommoss S; Winterhoff BJ; Kipp BR; Garcia JJ; Voss J; Halling K; Karnezis A; Senz J; Yang W; Prigge ES; Reuschenbach M; Doeberitz MV; Gilks BC; Huntsman DG; Bakkum-Gamez J; McAlpine JN; Anglesio MS
    BMC Cancer; 2015 May; 15():415. PubMed ID: 25986173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical and genetic characteristics of HPV-associated endocervical carcinoma with an invasive stratified mucin-producing carcinoma (ISMC) component.
    Park E; Kim YT; Kim S; Nam EJ; Cho NH
    Mod Pathol; 2021 Sep; 34(9):1738-1749. PubMed ID: 34103667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma.
    Kang S; Kim HS; Seo SS; Park SY; Sidransky D; Dong SM
    Gynecol Oncol; 2007 Jun; 105(3):662-6. PubMed ID: 17360030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients.
    Hirose S; Murakami N; Takahashi K; Kuno I; Takayanagi D; Asami Y; Matsuda M; Shimada Y; Yamano S; Sunami K; Yoshida K; Honda T; Nakahara T; Watanabe T; Komatsu M; Hamamoto R; Kato MK; Matsumoto K; Okuma K; Kuroda T; Okamoto A; Itami J; Kohno T; Kato T; Shiraishi K; Yoshida H
    Gynecol Oncol; 2020 Jan; 156(1):203-210. PubMed ID: 31757465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep Targeted Sequencing and Its Potential Implication for Cancer Therapy in Chinese Patients with Gastric Adenocarcinoma.
    Yu P; Wang Y; Yu Y; Wang A; Huang L; Zhang Y; Liu W; Wu H; Yao M; Du YA; Cheng X
    Oncologist; 2021 May; 26(5):e756-e768. PubMed ID: 33511732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
    Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
    Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lobular endocervical glandular hyperplasia is a neoplastic entity with frequent activating GNAS mutations.
    Matsubara A; Sekine S; Ogawa R; Yoshida M; Kasamatsu T; Tsuda H; Kanai Y
    Am J Surg Pathol; 2014 Mar; 38(3):370-6. PubMed ID: 24145653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.